Dopaminergic medications used in the treatment of patients with Parkinson's disease are
associated with motor and non-motor behavioural side-effects, such as dyskinesias and …

Functional, molecular and genetic neuroimaging has highlighted the existence of brain
anomalies and neural vulnerability factors related to obesity and eating disorders such as …

The neuronal substrate for binge eating, which can at times lead to obesity, is not clear. We
find that optogenetic stimulation of mouse zona incerta (ZI) γ-aminobutyric acid (GABA) …

Deep brain stimulation (DBS) is an established procedure for the symptomatic treatment of
Parkinson's disease. Several deep brain nuclei have been stimulated, producing a wide …

Importance Selection of the best deep brain stimulation (DBS) target—subthalamic nucleus
(STN) or globus pallidus interna (GPi)—for treatment of motor complications in Parkinson …

Purpose To perform a systematic review on the epidemiology, the health-related quality of
life (HRQoL) and economic burden of binge eating disorder (BED). Methods A systematic …

Impulse control disorders (ICDs) are a well-known adverse effect of dopamine agonists
(DAAs). This critical review aims to summarize data on the prevalence and factors …

Zona incerta (ZI) is a largely inhibitory subthalamic region connecting with many brain areas.
Early studies have suggested involvement of ZI in various functions such as visceral …

Despite the large number of measurement tools developed to assess problematic Internet
use, numerous studies use measures with only modest investigation into their psychometric …

Deep brain stimulation (DBS) is an emerging interventional therapy for well-screened
patients with specific treatment-resistant neuropsychiatric diseases. Some neuropsychiatric …